PDCD1 and neoplasm: PD-1 (CD279) acts on T cells as an inhibitory receptor and is present on several immune cells, such as tumour-infiltrating CD8+ and CD4+ T cells, monocytes, B cells, dendritic cells, and NK (natural killer) cells.